Long-term remission and biologic persistence rates: 12-year real-world data

Long-term remission and biologic persistence rates: 12-year real-world data

Abstract Background Biologic therapies have greatly improved outcomes in rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Yet, our ability to predict long-term remission and persistence or continuation of therapy remains limited. This study explores predictors of remission and persistence of...

Full description

Bibliographic Details
Main Authors: Kieran Murray, Matthew Turk, Yousef Alammari, Francis Young, Phil Gallagher, Tajvur Saber, Ursula Fearon, Douglas J. Veale
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Arthritis Research & Therapy
Subjects:
Rheumatoid arthritis
Psoriatic arthritis
Biologics
Remission
Online Access:https://doi.org/10.1186/s13075-020-02380-z

Similar Items

Similar Items